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Avian influenza viruses that cause infection and are
transmissible in humans involve changes in the re-
ceptor binding site (RBS) of the viral hemagglutinin
(HA) that alter receptor preference from a2-3-linked
(avian-like) to a2-6-linked (human-like) sialosides.
A human case of avian-origin H6N1 influenza virus
was recently reported, but the molecular mecha-
nisms contributing to it crossing the species barrier
are unknown. We find that, although the H6 HA RBS
contains D190V and G228S substitutions that poten-
tially promote human receptor binding, recombinant
H6 HA preferentially binds a2-3-linked sialosides,
indicating no adaptation to human receptors. Crystal
structures of H6 HA with avian and human receptor
analogs reveal that H6 HA preferentially interacts
with avian receptor analogs. This bindingmechanism
differs from other HA subtypes due to a unique com-
bination of RBS residues, highlighting additional
variation in HA-receptor interactions and the chal-
lenges in predicting which influenza strains and sub-
types can infect humans and cause pandemics.
INTRODUCTION
Although a multitude of different avian influenza A viruses have
been isolated, only three (H1N1, H2N2, and H3N2) have been
able to adapt for transmission in the humanpopulation, and these
viruses have led to influenza pandemics. To circulate in the hu-
man population, an avian influenza virus has to acquire the ability
to bind human receptors and lose affinity for avian receptors
before being able to transmit from human to human. In the last
two decades, an apparent increase has been observed in the re-
ported cases of new avian-origin influenza subtypes infecting
humans, including H9N2 (Peiris et al., 1999), H5N1 (‘‘bird flu’’)
(Beigel et al., 2005), H7N9 (Centers for Disease Control and Pre-
vention, 2013), and very recently H6N1 (Shi et al., 2013a; YuanCell Hoet al., 2013) and H10N8 (Chen et al., 2014). This increase in novel
zoonotic infections raises concern about the emergence of avian
subtypes that could give rise to novel human pandemics.
On June 21, 2013, the first case of a human infection by an
avian-origin H6N1 influenza A virus (A/Taiwan/2/2013, Taiwan2)
was reported by the Taiwan Centers for Disease Control (http://
www.cdc.gov.tw/english/info.aspx?treeid=bc2d4e89b154059b&
nowtreeid=ee0a2987cfba3222&tid=E36A5E9AB3D3A216). The
patient, a 20-year-old female, who had not been exposed to live
poultry, was hospitalized after she developed a high fever, cough,
headache, and muscle ache. She later fully recovered and no
human-to-human transmission of the H6N1 virus was reported
(Shi et al., 2013a; Yuan et al., 2013). Phylogenetic analysis of the
viral genes from this H6N1 human isolate suggested that an avian
virus A/Chicken/Taiwan/A2837/2013 was the possible origin of
sevenofeightgenesof theTaiwan2 (H6N1)virus (forHAsequence,
see Figure S1A available online), whereas the source of the
eighth gene, coding for PB2, was probably from A/Chicken/
Taiwan/0101/2012 (H5N2) (Shi et al., 2013a; Yuan et al., 2013).
H6N1 avian viruses are frequently isolated from birds and have
been circulating worldwide, including in North America, Europe,
and Asia (Cheung et al., 2007; Jonassen and Handeland, 2007;
Lee et al., 2006; Senne, 2003; Su¨ss et al., 1994). In Taiwan, the
H6N1 virus has been enzootic since the early 1970s (Lee et al.,
2006). Although to date only this one case of human infection by
an H6N1 virus has been reported, more widespread exposure
to H6 viruses likely has already occurred as antibodies against
H6 influenza A viruses have been detected in veterinarians in the
United States and in workers in live poultry markets in China
(Myers et al., 2007; Shortridge, 1992). Furthermore, virus replica-
tion studies show that some of the Taiwanese H6N1 viruses can
replicate in mice without adaptation (Lee et al., 2006).
Influenza virus is an enveloped virus that contains two surface
glycoproteins in its membrane envelope: hemagglutinin (HA)
and neuraminidase (NA). The HA is the major glycoprotein and
the target of neutralizing antibodies. The HA is a homotrimer
where each monomer is synthesized as an inactive single-chain
precursor (HA0) that is proteolytically cleaved into two subunits:
an N-terminal HA1 and a C-terminal HA2. The mature HA protein
is responsible for attachment of the virus to its natural receptors,
which are terminal sialic acids (N-acetylneuraminic acid [NeuAc])st & Microbe 17, 369–376, March 11, 2015 ª2015 Elsevier Inc. 369
on glycoprotein and glycolipids on the host cell, and for fusion of
the viral envelope with the host cell in the low pH of endosomal
compartments (Skehel and Wiley, 2000). So far 18 HA subtypes
(16 avian and 2 bat subtypes) have been identified (Tong et al.,
2013), based on serology and antigenic properties, and these
can be phylogenetically divided into two groups (Air, 1981;
Nobusawa et al., 1991). The H6 HA is within group 1 that also
includes H1, H2, H5, and H9 subtypes that have caused human
infections (Figure S1A).
The specificity of the HA for glycan receptors is believed to be
a key determinant of the viral host range (Matrosovich et al.,
2009), where the most important element for host specificity is
the linkage between the terminal sialic acid and the penultimate
galactose. HAs from avian viruses are characterized by their
preference for a2-3-linked sialosides, whereas HAs from human
viruses are specific for a2-6-linked sialosides. This specificity
difference contributes to the inability of most avian influenza
viruses to transmit in the human population (Parrish and Ka-
waoka, 2005), and changes in the binding specificity from a2-3
to a2-6 sialosides are therefore believed to be essential to cross
the species barrier and become human transmissible.
The HA receptor binding site (RBS) is located in the head
domain of the HA1 subunit and consists of three conserved
secondary elements, the 130 and 220-loops and the 190-helix,
and a number of conserved residues in the heart of the binding
site (Ha et al., 2001; Skehel and Wiley, 2000). Four key RBS
residues have been implicated in the avian-human specificity
switch (Matrosovich et al., 1997). In avian viruses, the 220-loop
contains Gly225, Gln226, and Gly228, whereas Glu190 is pre-
sent in the 190-helix (H3 numbering). For H1 subtypes,
Glu190Asp and Gly225Asp substitutions are critical for attaining
specificity for human receptors, as in the 1918 and 2009
pandemic H1N1 strains (Matrosovich et al., 2000; Stevens
et al., 2006b; Tumpey et al., 2007). In contrast, for the 1957
H2N2 and 1968 H3N2 pandemic viruses, Gln226Leu and
Gly228Ser substitutions were responsible for the switch be-
tween avian-type and human-type receptor specificity (Connor
et al., 1994; Matrosovich et al., 2000). These examples have
not proven predictive of the amino acid changes required
for conversion of receptor specificity in other subtypes. For
example, for avian H5N1 virus, Glu190Asp and Gly225Asp
mutations abolished receptor binding, while Gln226Leu and
Gly228Ser mutations produced partial recognition of a2-6 linked
receptors, but a2-3 binding was not lost (Stevens et al., 2006b).
Further mutations at Asn158 and Asn224, or at Gln196, or com-
bined with the loss of the N-linked glycan at Asn158, were suffi-
cient to switch receptor specificity for H5 viruses to become
transmissible in mammals (Chen et al., 2012; de Vries et al.,
2014; Herfst et al., 2012; Imai et al., 2012).RESULTS
Structural Characterization of Taiwan2 H6N1 HA
The H6N1 A/Taiwan/2/2013 virus is one of several emerging
influenza viruses over the past 2 years, including H7N9 and
H10N8, which have caused human infection but have not yet
spread in the human population (Vachieri et al., 2014). The fre-
quency of these infections has elevated concerns that these370 Cell Host & Microbe 17, 369–376, March 11, 2015 ª2015 Elsevieviruses will acquire human-type receptor specificity allowing
them to transmit between humans.
To analyze the receptor binding of H6N1, we first performed
sequence alignment of the Taiwan2 H6N1 HA with human
pandemic strains andwith avian subtypes from emerging viruses
that have caused sporadic outbreaks of human infections over
the last few years. Taiwan2 H6 HA contains a unique combina-
tion of four key residues in the RBS not seen previously in human
influenza viruses or avian viruses that sporadically infect humans
(Figure S1B). The H6 190-helix contains an unusual aliphatic
substitution of Val at position 190 instead of an acidic residue
in all other avian and human subtypes (i.e., Glu or Asp for avian
and human subtypes, respectively). In the 220-loop, H6 HA con-
tains the G228S substitution that is associated with the receptor
specificity switch of the H2 and H3 human pandemic viruses
(Connor et al., 1994; de Graaf and Fouchier, 2014). In addition,
two other substitutions could influence receptor binding. At
position 222, H6 HA has a small hydrophobic Ala instead of a
charged or polar residue (Lys or Gln) in all other subtypes, except
for H3, where it is an aromatic residue (Trp). Taiwan/2/2013
H6 HA also contains Leu at position 186 instead of Pro, as in
A/Chicken/Taiwan/A2837/2013 (Shi et al., 2013a) (Figure S1B).
To investigate the structural features and properties of this
H6 HA, its crystal structure was determined at 2.5 A˚ resolution
(TableS1).Overall, thestructure is similar toother known influenza
A HAs (Figure 1A), and the disposition of the HA head relative to
the stem is most similar to H2N2 HA (PDB ID code 3KU5). Six po-
tential N-linked glycosylation sites per HA protomer are predicted
(Wang et al., 2014) (five in HA1), but interpretable electron density
consistentwith glycosylation is observedonly at Asn21 (protomer
C), Asn32 (A), and Asn 169 (A and C) from HA1 and Asn154 (C)
fromHA2, but not at Asn291 and Asn296, presumably due to dis-
order (i.e., for the trimer, for 18 potential glycosylation sites, only
five glycans could be modeled) (Figure 1A). Superposition of the
H6HAonother avian andhumanHAsconfirms thatH6 is structur-
ally closest to H1, H2, and H5 (group 1 HAs) (Ca root-mean-
square deviation [rmsd] of 0.8–1.3 A˚ compared to 2.4–2.5 A˚ for
group 2 H3 and H7). Similar results were also obtained by super-
position of the HA1, HA2, and RBS subdomains (Figure 1C; Table
S2). The H6 differs from other HAs due to insertion of Asp at posi-
tion 144a, and a one-residue insertion of Asp at position 157a in
the 150-loop compared to H1, H2, H3, and H5 HAs (Figures
S1B and 1C). A similar insertion of residues in the 150-loop was
found for H7 HA, which contains two additional residues at
positions 158a and 158b. The H6 RBS, like all other influenza A
HAs, has a conserved floor of Tyr98, Trp153, His183, and
Tyr195 (Skehel andWiley, 2000) for binding the sialic acid moiety
of the receptor. The surrounding 130-loop, 150-loop, 220-loop,
and190-helix (Figure 1B) delineate the sides andends of theRBS.
Receptor Specificity of Taiwan2 H6N1 HA
To determine the receptor specificity, the Taiwan2 H6 HA was
expressed in insect cells and analyzed on a custom sialoside
glycan array comprised of diverse a2-3 and a2-6 sialosides
that correspond to N-linked and O-linked glycans, as well as
linear fragments of glycans, on mammalian glycoproteins and
glycolipids (Figure 2) (Stevens et al., 2006a; Raman et al.,
2014). The use of recombinant HA protein eliminates possible
interference from the NA on the virus that preferentially cleavesr Inc.
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Figure 1. Crystal Structure of Taiwan2 H6N1 HA
(A) Schematic representation of the H6 HA trimer. One protomer is colored in cyan and green for the HA1 and the HA2 subunits, and the RBS is marked with red
rectangle. N-linked glycans that could be modeled in the electron density maps are in green spheres, and the corresponding asparagine is shown in sticks and
labeled in black. Two other potential glycosylation sites (Asn291 and Asn 296) are labeled in red.
(B) Schematic representation of the H6 HA RBS with sticks representing key residues for receptor binding (colored in green and labeled). The four highly
conserved residues in the RBS are labeled in red. The H6 RBS contains Val in position 190 and Ser in position 228.
(C) Superposition of the RBS subdomains of H6 HA (black) and pandemic H1 (yellow, PDB ID code 3AL4), H2 (red, PDB ID code 3KU5), H3 (cyan, PDB ID
code 4FNK), A/Vietnam/1203/2004 H5 (green, PDB ID code 2FK0), and A/Shanghai/2/2013 H7 (magenta, PDB ID code 4N5J) HAs (see also Figure S1;
Tables S1 and S2).
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Figure 2. Receptor Binding Specificity of Taiwan2 H6N1 HA
(A) Glycan microarray analysis of recombinant H6 HA protein expressed in
insect cells demonstrates specific binding to a subset of a2-3 sialosides and to
a mixed biantennary glycan.
(B and C) The HAs of the A/Vietnam/1203/04 H5N1 (B) and H1N1 seasonal
strain KY/07 (C) served as controls for a2-3 and a2-6 sialoside binding
specificity. The mean signal and standard error were calculated from six in-
dependent replicates on the array. a2-3 linked sialosides in white bars (glycans
3–35 on the x axis), a2-6 linked sialosides in black (glycans 36–56), and mixed
biantennary glycans containing both a2-3 and a2-6-linked sialylated glycans
in gray bars (glycans 57 and 58). Glycans 1 and 2 are nonsialylated control
glycans (see also Figure S2 and Table S3).a2-3 linked sialosides. Selective binding was observed to a2-3
sialosides with no detectable binding to a2-6 glycans (Figure 2).
More specifically, the H6 HA bound preferentially to long
branched O-linked and N-linked glycans terminating with a2-3
linked sialic acids (numbers 24–27) and fucosylated glycan
structures (Figure 2A). Recombinant H6 HA expressed in mam-
malians cells bound with reduced avidity to the same glycans
(Figure S2), a property observed previously for the H7N9 HA
(Xu et al., 2013) that we attribute to the larger glycans expressed
by mammalian cells (Stevens et al., 2006a; de Vries et al., 2010).
Structural Characterization of Taiwan2 H6N1 HA in
Complex with Avian Receptor Analogs
Crystal structures of H6 HA in complex with avian receptor ana-
logs 30-SLN (NeuAca2-3Galb1-4GlcNAc) and LSTa (NeuAca2-
3Galb1-3GlcNAcb1-3Galb1-4Glc) were determined at 2.3 A˚
and 2.4 A˚, respectively (Figure 3; Table S1). Electron density
for 30-SLN and LSTa was observed in only one RBS of the trimer,372 Cell Host & Microbe 17, 369–376, March 11, 2015 ª2015 Elsevieas the two other binding sites are blocked by the HA1 C terminus
of a symmetry-related molecule in the crystal. As in other HA
subtypes, Sia-1 of 30-SLN and LSTa forms the usual seven
conserved hydrogen bonds with the 220-loop and 130-loop
(Figures 3B and 3C). Other conserved interactions include
a hydrogen bond between the Tyr98 hydroxyl and the sialic
acid (Sia-1) 8-hydroxyl and hydrophobic interactions between
Trp153 and Sia-1 C8 and C9 (Figures 3B and 3C). In addition,
the H6 RBS contains substitutions at two residues that normally
contribute to Sia-1 binding in avian HA subtypes, E190V and
G228S. The Gly228Ser substitution, which is also found in
human H2 and H3 isolates, eliminates a conserved hydrogen
bond between the Sia-1 9-hydroxyl group and the Gly228
main-chain carbonyl. Instead, the Ser228 hydroxyl hydrogen
bonds with the Sia-1 9-hydroxyl that results in a small displace-
ment of Sia-1 away from the 220-loop toward the 130-loop.
Furthermore, the Glu190Val substitution removes a conserved
polar interaction of avian receptor analogs with the 190-helix
between Sia-1 and the Glu190 carboxyl.
The second (Gal) and third (GlcNAc) sugars in 30-SLN and
LSTa exit the RBS above the 220-loop (Figures 3B and 3C).
For avian HA subtypes, cis and trans conformations of Sia-Gal
bond (C1Sia-C2Sia-O-C3Gal) of avian receptors are found (Figures
S4A and S4B). Most analogs bind in a trans conformation that is
stabilized by hydrogen bonding of Gal-2 to Gln226 and, in some
structures, also to Glu190 (Lin et al., 2009; Liu et al., 2009;
Xiong et al., 2013a; Xu et al., 2013). For ferret-transmissible
H5 (Xiong et al., 2013a; Zhang et al., 2013) and human H7N9
isolates (Shi et al., 2013b; Xiong et al., 2013b; Xu et al., 2013),
the cis conformation is stabilized by hydrogen bonding of the
Gal-2 6-hydroxyl to the Gly225 main chain and by hydrophobic
interaction between Gal-2 C3 and Leu226 (except for the
A/Shanghai/1/2013 H7N9 HA L226Q mutant in complex with
30-SLNLN, where the hydrophobic face of Gal-2 makes hydro-
phobic interactions with other hydrophobic residues of the
RBS [PDB ID code 4LKG] [Shi et al., 2013b]). In addition,
GlcNAc-3 makes a polar interaction with Lys/Gln222 (for H5
and H7 Has, respectively) (Figure S4).
In H6 HA, 30-SLN and LSTa bind in a cis conformation,
although no hydrophobic residue at position 226 or polar residue
at position 222 is present (Gln226 and Ala222 in H6). The cis
conformation is similar to the conformation in receptor struc-
tures, with HAs of ferret-transmissible H5 (Xiong et al., 2013a;
Zhang et al., 2013) and human H7N9 isolates (Shi et al., 2013b;
Xiong et al., 2013b; Xu et al., 2013) and stabilized by interaction
of Gal-2 with Gly225 and by hydrogen bonding of Gal-2 O4
to Asn137 (Figures 3B and 3C). A similar interaction between
Gal-2 and the 130-loop has only been reported for an avian
analog complex with the transmissible H5 mutant (Zhang et al.,
2013). For the 30-SLN complex, a hydrogen bond is formed
between the GlcNac-3 3-hydroxyl to the Gly225 main chain. In
addition, hydrophobic interactions are made from GlcNAc-3
C8 to Arg227 CD in the 30-SLN and from GlcNAc-3 C6 to
Leu186 in the LSTa complex (Figures 3B and 3C).
Structural Characterization of Taiwan2 H6N1 HA
in Complex with a Human Receptor Analog
Binding of human receptor analogs to the H6 HA is not detected
on the glycan array. Although intrinsic differences in affinity forr Inc.
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Figure 3. Crystal Structures of the H6 HA in
Complex with Avian Receptor Analogs
(A) Cartoon representation of the glycan structures
of avian receptor analogs 30-SLN and LSTa. Sia is
the abbreviation for sialic acid, Gal for galactose,
GlcNAc for N-acetylglucosamine, and Glc for
Glucose.
(B and C) Stereorepresentations of the interactions
between the H6 HA RBS and the avian receptor
analogs. The conserved secondary elements of
the HA RBS (130-loop, 190-helix, and 220-loop)
are labeled and shown in cartoon representation.
Selected residues and receptor analogs are
labeled and shown in sticks. The RBS is colored in
gray and the receptor analogs in yellow. Shown
are hydrogen bond interactions of Sia-1 and Gal-2
and GlcNAc-3 of 30-SLN (B) and LSTa (C) with the
H6 HA RBS (see also Figures S3 and S4).a2-3 and a2-6 linked sialosides are usually small, preferential
binding to a2-3 linked sialosides over a2-6 linked sialosides is
observed as a consequence of the avidity amplification resulting
from the HA complex used in the experiment (Sauter et al., 1989),
which mimics the multivalent interactions of the HAs on the
viral surface. The very weak monovalent binding of a2-6 linked
sialosides can be detected in the crystal soaked at high concen-
trations of ligand (5 mM; HA:ligand stoichiometry of 1:55), help-
ing to clarify the observed preference in receptor specificity
(Xu et al., 2012). In the H6 HA structure with 60-SLN at 2.2 A˚
(Figure 4; Table S1), electron density was found for only two
sugars, compared to three sugars observed with a2-3 linked
analogs, consistent with the much weaker interaction of a2-6
sialosides (Figure 2). Hydrogen bonding interactions of Sia-1
with the RBS are largely conserved as in the 30-SLN and LSTa
complexes, except for the polar interaction between the Sia-1
carboxyl and Asn137 due to a side-chain rotamer change
(Figure 4A) (Lin et al., 2009, 2012; Liu et al., 2009; Shi et al.,
2013b; Xu et al., 2012). The difference in the phi angle may pre-
vent a steric clash between Gln226 and Gal-2 C5 and enable
hydrogen bond interactions between Gln226 and Gly225 and
Gal-2 of 60-SLN. Similar interactions with a human receptor
analog were observed in an avian AH-H7N9 L226Q mutant
with 60-SLNLN (PDB ID code 4LKK) (Xiong et al., 2013b). Further-Cell Host & Microbe 17, 369–37more, mutation of Leu226 to Gln results
in changes in the phi and psi angles
of the Sia-Gal linkage compared to
the AH-H7N9 wild-type. Consequently,
Gal-2 hydrogen bonds with Gln226 and
Gly225 main chain (Figure S4) (Xiong
et al., 2013b). This conformation enables
hydrogen bonds to be formed between
the Gal-2 4-hydroxyl of 60-SLN with
Gln226 and Gly225 main-chain carbonyl
(Figure 4B).
DISCUSSION
The first H6 flu virus was isolated in 1965
from turkeys and since then from abroader range of avian species. Recent biological characteri-
zation of 256 H6 viruses from live poultry markets in China re-
vealed that around 34% of H6N2 and H6N6 viruses could bind
human-type receptors while maintaining an overall preference
for avian receptors (Wang et al., 2014). In addition, most of
these viruses can replicate in the respiratory system of mice
and guinea pigs without preadaptation (Wang et al., 2014).
Although the Gly228Ser mutation was not detected in these
isolates, an Ala128Ser substitution, previously associated with
human-like receptor binding, was present in a few viruses, but
thismutation does not increase binding to human-type receptors
(Wang et al., 2014).
Our structural and biological studies indicate that the
A/Taiwan/2/2013 H6N1 virus isolated from an infected human
retains the receptor binding properties of an avian virus.
Although the H6N1 HA RBS maintains the overall architecture
of other HAs, it contains unique substitutions or combinations
of residues (Leu186, Val190, Ala222, and Ser228) that influence
interaction with receptor analogs. Substitution of the highly
conserved acidic residue at position 190 to Val in concert
with acquisition of Leu186 increases the hydrophobicity of the
190-helix and precludes formation of hydrogen bonds between
receptor analogs and the 190-helix. However, the less frequent
cis conformation for avian receptors promotes interaction6, March 11, 2015 ª2015 Elsevier Inc. 373
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Figure 4. Crystal Structure of the H6 HA in
Complex with a Human Receptor Analog
(A) Cartoon representation of the glycan structure
of human receptor analog 60-SLN.
(B) Stereorepresentation of the hydrogen bond
interactions of Sia-1 and Gal-2 of 60-SLN with the
H6 HA RBS. The conserved secondary elements
of the HARBS (130-loop, 190-helix, and 220-loop),
as well as Tyr 98 and Trp153, are labeled and
shown in cartoon representation (see also Figures
S3 and S4).between Gal-2 of avian analogs and Asn137, thereby enhancing
binding with the 130-loop, previously only seen for LSTa in com-
plex with the HA of a transmissible H5 mutant (Zhang et al.,
2013). The H6 crystal structure reveals weaker interaction with
60-SLN (Figures 4 and S3), as reflected by electron density for
only two sugars and higher B values in the crystal structure
for the ligand versus protein (ratio of the B values for receptor
homolog/HA protein is 1.23 for 30-SLN and 1.57 for LSTa
compared to 1.72 for 60-SLN). These structural studies of the
H6 HA in complex with tri- and pentasaccharides therefore
reveal the structural basis for the preferential specificity for
avian versus human receptor analogs. However, other aspects
required for transmission could also be impacted by additional
characteristics of natural glycan receptors on human lung
tissues that are yet to be characterized.
In the last 2 years, an unprecedented number of zoonotic
infections of avian-origin viruses have been detected in the
human population (H7N9, H10N8, and H6N1) that may be a
reflection of new zoonotic events, increased surveillance, or
better detection methods and technologies, or a combination
of all of these. Notwithstanding, these increasing numbers of
zoonotic infections raise concern for the emergence of new
pandemic viruses that contain these HA and NA subtypes
(Xu et al., 2013; Vachieri et al., 2014; Zhang et al., 2015). Of
primary concern is the potential of these viruses to switch their
specificity from avian-type to human-type receptors and, as a
result, potentially acquire the ability to transmit from human-to-
human and thereby facilitate spread in the human population
(de Graaf and Fouchier, 2014). Human H7N9 and H10N8 isolates
have to date largely retained avian-type receptor specificity
(Vachieri et al., 2014; Xu et al., 2013; Zhang et al., 2015), and
here we show that the recently isolated H6N1 virus also retains
avian-type receptor specificity. RBSmutations that switch spec-
ificity from avian-type to human-type receptors in the H1, H2,
and H3 subtypes that transmit in humans are well documented
(Connor et al., 1994; de Graaf and Fouchier, 2014; Stevens
et al., 2006a). Furthermore, mutations that produce a receptor
switch in the H5N1 virus have been demonstrated to increase
transmission in ferrets (de Graaf and Fouchier, 2014; Imai374 Cell Host & Microbe 17, 369–376, March 11, 2015 ª2015 Elsevier Inc.et al., 2012). Nevertheless, no clear rules
have emerged for what it takes to
switch receptor specificity for the other
14 HA subtypes (12 avian). Thus, until
further insights and better methods for
predicting receptor specificity are devel-
oped, constant surveillance is requiredto monitor any changes in avian and other zoonotic viruses
that could increase their potential for transmission in the human
population.
EXPERIMENTAL PROCEDURES
Expression and Purification of H6 in Insect Cells
The H6 HA cDNA of H6N1 A/Taiwan/2/13 (Global Initiative on Sharing All
Influenza Data [GISAID] isolate ID: EPI_ISL_143275) was synthesized by Life
Technologies and cloned into a pFastBac vector. Wild-type H6 HA was ex-
pressed in Hi5 insect cells with an N-terminal gp67 signal peptide, a C-terminal
thrombin cleavage site, a foldon trimerization sequence, and a His6 tag and
expressed as described previously (Stevens et al., 2006b). The expressed
HA0 was purified via a His-tag affinity purification, dialyzed against 20 mM
Tris-HCl (pH 8.0), 100 mM NaCl, and then cleaved by trypsin (New England
Biolabs, Ipswich, MA) to produce uniformly cleaved (HA1/HA2) and to remove
the trimerization domain andHis6 tag. The digested protein was purified further
by gel filtration chromatography using a Superdex-200 column (Pharmacia).
The HA protein eluted as a trimer and was concentrated to 5 mg/ml. Additional
details, as well as expression of H1 and H5 HAs as controls, are given in the
Supplemental Experimental Procedures.
Crystallization and Structural Determination of H6 HA
Crystals of H6 HAwere obtained using the vapor diffusion sitting-dropmethod
(drop size 4 ml) at 20C against a reservoir solution containing 10 mM NiCl2,
0.1 M Tris (pH 8.5), 20% (w/v) MPEG 2000, and 20% glycerol. Complexes
with receptor analogs were obtained by soaking HA crystals in the reservoir
solution that contained glycan ligands in a final concentration of 5 mM. Prior
to data collection, the crystals were flash cooled in liquid nitrogen. Diffraction
data were collected at the Advanced Photon Source (APS) and at the Stanford
Synchrotron Radiation Lightsource (SSRL). The H6 apo structure was solved
by molecular replacement with an H1 HA structure (PDB ID code 4M4Y) as a
search model. The H6 HA apo structure then became the starting model for
structure determination of the H6 HA-glycan complex structures.
Glycan Microarray Analysis of HAs Expressed in Insect and
Mammalian Cells
Purified, soluble trimeric HA was precomplexed with horseradish peroxidase
(HRP)-linked anti-strep-tag mouse antibody and with Alexa 647-linked anti-
mouse IgG (4:2:1 molar ratio) prior to incubation for 15 min on ice in 100 ml
PBS-T, and incubated on the array surface in a humidified chamber for
90 min. Slides were subsequently washed and dried by centrifugation
and immediately scanned for FITC signal. Fluorescent signal intensity was
measured using Imagene, and mean intensity minus mean background was
calculated. Additional details are given in the Supplemental Experimental
Procedures.
ACCESSION NUMBERS
Atomic coordinates and structure factors have been deposited in the Protein
Data Bank (PDB) under ID codes 4XKD for Taiwan2 H6 HA in apo form and
4XKE, 4XKF, and 4XKG in complex with 30-SLN, LSTa, and 60-SLN.
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